YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

Terminated

Conditions: Stress Hyperglycemia
Diabetes Mellitus Type 2

First Posted Date: 2014-02-21

Last Posted Date: 2016-09-05

Lead Sponsor: Yale University

Target Recruit Count: 1

Registration Number: NCT02068989

Locations: 🇺🇸
Norwalk Hospital, Norwalk, Connecticut, United States
🇺🇸
Yale New Haven Hospital St. Raphael Campus, New Haven, Connecticut, United States

AbATE Follow-Up Study

Completed

Conditions: Diabetes Mellitus, Type 1

First Posted Date: 2014-02-20

Last Posted Date: 2018-01-17

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT02067923

Locations: 🇺🇸
Church Street Research Unit, New Haven, Connecticut, United States

Digestive Endoscopy Suite Radiation Controlling Protective Strategies

Early Phase 1

Completed

Conditions: Radiation Exposure

Interventions: Device: sterile identical sham drape
Device: lead-free protective drape containing bismuth and antimony (RADPAD®)

First Posted Date: 2014-02-14

Last Posted Date: 2015-08-20

Lead Sponsor: Yale University

Target Recruit Count: 2

Registration Number: NCT02063841

Locations: 🇺🇸
Endoscopy Center, Smilow Cancer Center, Yale New Haven Hospital, New Have, Connecticut, United States

Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

Not Applicable

Completed

Conditions: Early Stage Estrogen Receptor (ER) Positive Breast Cancer
Breast Cancer

Interventions: Behavioral: BCI Assay Results

First Posted Date: 2014-02-06

Last Posted Date: 2016-01-08

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT02057029

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand

Completed

Conditions: Hypoglycemia

Interventions: Other: Norepinephrine Transporter (NET) ligand

First Posted Date: 2014-02-05

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT02056249

Locations: 🇺🇸
PET Center, YCCI Hospital Research Unit (HRU), New Haven, Connecticut, United States

De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

Terminated

Conditions: De Novo Autoimmune Hepatitis

Interventions: Other: Adult transplanted subjects with de novo autoimmune hepatitis
Other: Pediatric transplant subject with d-AIH
Other: Pediatric transplant subject with acute rejection
Other: Pediatric control subjects
Other: Adult non-transplant patients with auto-immune hepatitis
Other: Pediatric transplant subject with chronic rejection
Other: Adult non-transplant subjects with chronic hepatitis C virus

First Posted Date: 2014-02-05

Last Posted Date: 2021-12-10

Lead Sponsor: Yale University

Target Recruit Count: 157

Registration Number: NCT02056054

Hormones and Physical Exercise (HOPE) Study

Not Applicable

Completed

Conditions: Arthralgia
Breast Cancer

Interventions: Behavioral: Exercise
Behavioral: Attention Control (Health Education)

First Posted Date: 2014-02-05

Last Posted Date: 2020-03-05

Lead Sponsor: Yale University

Target Recruit Count: 121

Registration Number: NCT02056067

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Ranolazine and Microvascular Angina by PET in the Emergency Department

Phase 4

Completed

Conditions: Microvascular Angina

Interventions: Drug: Placebo
Drug: Ranolazine

First Posted Date: 2014-01-31

Last Posted Date: 2017-05-16

Lead Sponsor: Yale University

Target Recruit Count: 31

Registration Number: NCT02052011

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis

Not Applicable

Completed

Conditions: Autoimmune Hepatitis

Interventions: Other: Low Salt Diet
Other: Liberal salt diet

First Posted Date: 2014-01-31

Last Posted Date: 2021-07-28

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT02050646

Guanfacine Clinical Trial for Smoking Cessation

Phase 2

Completed

Conditions: Smoking Cessation

Interventions: Drug: Placebo
Drug: Guanfacine

First Posted Date: 2014-01-31

Last Posted Date: 2021-12-29

Lead Sponsor: Yale University

Target Recruit Count: 121

Registration Number: NCT02051309

Locations: 🇺🇸
Yale Center for Clinical Investigations, Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy